- Nachrichtendetail
-
01.04.2024 02:34:39 - dpa-AFX: *EISAI COMPLETES SUBMISSION OF LEQEMBI SBLA FOR IV MAINTENANCE DOSING FOR TREATMENT OF EARLY ALZHEIMER'S DISEASE TO FDA
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Biogen | 789617 | NASDAQ | 227,575 | 10.06.24 20:17:24 | +2,145 | +0,95% | 227,480 | 227,670 | 224,520 | 225,430 |
